| ID | Sequence | Length | GC content |
|---|---|---|---|
| GACACCUCCGCGGGCACUCACCCAGGCCGGCCGCUCACAACCGAGCGCA… | 1697 nt | 0.5616 | |
| AAAAGCGAAAGCGAAUGCGACUGGCGGGGCGGCAGGUCCCAGAGCAGCG… | 1810 nt | 0.5597 | |
| GUAUUUUUAGUAGAGAUGGGGUUUCACCAUGUUGGCCAGGCUAGUCUCG… | 2003 nt | 0.5227 | |
| AUGCAAGAGACAGGCUGGCUGUCCUGGCGGGAAGGAGCAGAAUAUCUGA… | 1840 nt | 0.5326 | |
| GACACCUCCGCGGGCACUCACCCAGGCCGGCCGCUCACAACCGAGCGCA… | 1598 nt | 0.5569 | |
| CUGGGCAGCGCUCGCCCGGGGAGUCCAGCGGUGUCCUGUGGAGCUGCCG… | 1566 nt | 0.5594 | |
| CUGGGCAGCGCUCGCCCGGGGAGUCCAGCGGUGUCCUGUGGAGCUGCCG… | 1467 nt | 0.5542 |
This gene encodes a cytokine receptor that specifically binds interleukin 15 (IL15) with high affinity. The receptors of IL15 and IL2 share two subunits, IL2R beta and IL2R gamma. This forms the basis of many overlapping biological activities of IL15 and IL2. The protein encoded by this gene is structurally related to IL2R alpha, an additional IL2-specific alpha subunit necessary for high affinity IL2 binding. Unlike IL2RA, IL15RA is capable of binding IL15 with high affinity independent of other subunits, which suggests distinct roles between IL15 and IL2. This receptor is reported to enhance cell proliferation and expression of apoptosis inhibitor BCL2L1/BCL2-XL and BCL2. Multiple alternatively spliced transcript variants of this gene have been reported.[provided by RefSeq, Apr 2010]
A study in mice demonstrated that the IL15RA transcript increased in relative abundance within 0.5 hours postmortem [Pozhitkov et al. DOI:10.1098/rsob.160267].